These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 618187)

  • 1. [Whole-body retention studies of 169Yb-citrate.--Estimation of radiation dose to humans from 169Yb-citrate (author's transl)].
    Ando A; Mori H; Ando I; Hiraki T; Hisada K
    Radioisotopes; 1977 Sep; 26(9):602-5. PubMed ID: 618187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Whole-body retention studies of 167Tm-citrate.--Estimation of radiation dose to human from 167Tm-citrate--(author's transl)].
    Hiraki T; Ando A; Mori H; Ando I; Sakamoto K; Amano R; Kojima K; Hisada K
    Radioisotopes; 1978 Feb; 27(2):85-9. PubMed ID: 417386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autoradiographic visualization of the retention of 169Yb-citrate in bone and its removal by drugs (author's transl)].
    Chu SP; Jiang J
    Zhongguo Yao Li Xue Bao; 1981 Mar; 2(1):64-6. PubMed ID: 6461205
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposomal preparations of calcium- or zinc-DTPA have a high efficacy for removing colloidal Ytterbium-169 from rat tissues.
    Blank ML; Byrd BL; Cress EA; Washburn LC; Snyder F
    Toxicology; 1984 Apr; 30(4):275-81. PubMed ID: 6729826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Body retention of 169Yb-citrate and its excretion by 4 chelating agents].
    Zhu SP; Zhao JY; Su KY; Mo QZ; Wang GL
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):285-8. PubMed ID: 6240908
    [No Abstract]   [Full Text] [Related]  

  • 6. [Penetration of 169Yb-citrate through intact and abraded skins].
    Zhu SP; Wang CD; Cao GF; Wang GL
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):288-9. PubMed ID: 6240909
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long term biokinetics of 169Yb following injection as citrate, hydroxyethylethylenediaminetetraacetate and nitrilotriacetate].
    Schomäcker K; Scheidhauer K; Franke WG; Weiss S; Lindner L; Jantsch K; Shukla SK; Limouris GS
    Nuklearmedizin; 1993 Apr; 32(2):99-105. PubMed ID: 8479937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ytterbium-169: calculated physical properties of a new radiation source for brachytherapy.
    Mason DL; Battista JJ; Barnett RB; Porter AT
    Med Phys; 1992; 19(3):695-703. PubMed ID: 1508110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Retention of (169Yb) ytterbium citrate in rats by fluorescence sensitization autoradiography (author's transl)].
    Zhu SP
    Zhongguo Yao Li Xue Bao; 1981 Sep; 2(3):197-200. PubMed ID: 6462013
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of distribution of 169Yb, 69Ga and 111In in tumor tissues by macroautoradiography; comparison between viable and necrotic tumor tissues].
    Ando A; Doishita K; Sanada S; Ando I; Hiraki T
    Radioisotopes; 1977 Jan; 26(1):13-8. PubMed ID: 577017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Accumulation mechanism of radioisotopes for diagnosis of tumors (67ga-citrate, 169yb-citrate and 51cr-bleomycin)].
    Orii H
    Rinsho Hoshasen; 1973 Mar; 18(3):211-2. PubMed ID: 4122817
    [No Abstract]   [Full Text] [Related]  

  • 12. [Accumulation of 169Yb-citrate in malignant tumor].
    Higashi T; Fujimura T; Nakayama Y; Hisada T; Tomura K
    Kaku Igaku; 1973 Feb; 10(1):27-35. PubMed ID: 4738849
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of subcellular distribution of 169Yb and 111In in tumor and liver (author's transl)].
    Ando A; Takeshita M; Ando I; Hiraki T; Hisada K
    Radioisotopes; 1977 Mar; 26(3):169-74. PubMed ID: 199917
    [No Abstract]   [Full Text] [Related]  

  • 14. The relative biological effectiveness of ytterbium-169 for low dose rate irradiation of cultured mammalian cells.
    Plume CA; Daly SE; Porter AT; Barnett RB; Battista JJ
    Int J Radiat Oncol Biol Phys; 1993 Apr; 25(5):835-40. PubMed ID: 8478234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of tumor and liver concentration of 111In and 169Yb: 111In and 169Yb binding substances in tumor tissues and liver.
    Ando A; Ando I; Hiraki T; Takeshita M; Hisada K
    Eur J Nucl Med; 1982; 7(7):298-303. PubMed ID: 6214397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioisotopes used in the diagnosis of bone diseases].
    György T; Zsigmond K; Pálimre ; János T; Márton F; Pál NT
    Magy Traumatol Orthop Helyreallito Seb; 1976; 19(2):146-51. PubMed ID: 6836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The radiation dose to children bone scintigraphy with 99mTc-phosphate compounds (author's transl)].
    Eissner D; Wolf R
    Rofo; 1980 Mar; 132(3):331-5. PubMed ID: 6253368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of 169Yb-cis-dichlorodimethionine platinum scintigraphy in patients with malignant lymphomas.
    Kukulski K; Liniecki J; Brykalski D; Zadrozna O; Kapuściński J
    Nucl Med Commun; 1995 Sep; 16(9):747-55. PubMed ID: 7478407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal encapsulated Zn-DTPA for removing intracellular 169Yb.
    Blank ML; Cress EA; Byrd BL; Washburn LC; Snyder F
    Health Phys; 1980 Dec; 39(6):913-20. PubMed ID: 6782042
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.